Heng Rui, a "Pharma Express" company, took the exclusive interest in PI3k inhibitors in China
Time of Update: 2021-03-08
(Sina Pharmaceutical News) Microcore Biology: Theo Ronnie capsule approved clinical trial February 9, microcore bio-announcement, the company recently received NMPA's new drug clinical trial application "acceptance notice", the product name is Theo Ronnie capsule.
Tiger Pharma: Subsidiary and Kyusek Pharmaceuticals established the United States FJ Company to provide drug research and development one-stop service
Time of Update: 2021-02-22
Tiger Pharma announced on the evening of January 24th that Frontage Laboratories, Inc., a subsidiary of the company, had announced that it would not be in a company that would be in a state of force. ("Fangda Pharmaceuticals") recently signed
1.26 billion U.S. dollars holding Indian pharmaceutical company Fosun Pharma accelerated internationalization
Time of Update: 2021-02-21
wholly-owned subsidiary FOSUNPHARMAINDUSTRIALPTE.LTD. (here referred to as the acquirer), Fosun Industrial (Hong Kong) Co., Ltd. (the joint acquirer) and Gland's existing shareholders and related parties signed the relevant agreement on the 28th. Data
Asasin Pharma has been certified as an FDA orphan drug, with a total of 9 chinese pharmaceutical companies in 2020
Time of Update: 2021-01-19
, as of now, Asah Pharmaceuticals has obtained 9 FDA orphan drug certifications in research and development of new drugs, the largest number of Chinese enterprises.
Alice Pharma is officially listed on the Company's board today
Time of Update: 2021-01-07
., Ltd. According to the results of the Ailes Pharmaceuticals issue announcement, the company's share issue price of 22.73 yuan per share, a total size of about 2,045.7 million yuan, the funds raised will be mainly used for new drug research
Chinese pharmaceutical companies rob the market for rare diseases! Asasin Pharma was awarded 8 orphan drug qualifications
Time of Update: 2021-01-05
according to statistics, thought Di, and platinum medicine, cornerstone pharmaceutical industry, Junshi biological, Xinda biology, Baiji Shenzhou and other enterprises have PD-1/L1 inhibitors to obtain orphan drugs Qualifications, including nasopharyngeal
The well-known pharmaceutical company Fu Pharma 360 million was sold.
Time of Update: 2020-08-13
Pharmaceutical Network August 7th - On August 5, Renfu Pharmaceutical Group Co., Ltd. ("HumanFu Pharmaceuticals") announced that it intends to transfer 70% of its stake in Sichuan Renfu Pharmaceutical Co., Ltd. to Chongqing Pharmaceuticals (Group
Fosun Pharma, medicine Ming Kant again shot! These innovation companies will be in the spotlight by 2020
Time of Update: 2020-07-09
New Element Almedicine was founded in 2012 and is mainly engaged in the development of innovative drugs for metabolic diseases and anti-cancer drugs, including 7 innovative drugs for the treatment of gout, hyperuric acidemia, non-alcoholic
Lu Anti-Pharma plans to invest 45.6 million yuan to set up a biomanufacturing company
Time of Update: 2020-07-03
Lu Anti-Pharma intends to invest 45.6 million yuan to set up Lu Anti-Biomanufacturing Company, the company registered capital of 48 million yuan, the company's shareholding of 95%. In addition, the Company intends to sell its 31.25% stake
Broad Pharma to participate in Belgian company to introduce mRNA vaccine technology
Time of Update: 2020-06-15
On June 1, BroadPharma announced that the Group had recently entered into an equity investment agreement with eTheA Immunres NV (eTheRNA) in Belgium, which will invest 9 million euros in eTheRNA after the terms agreed in the investment agreement have
Broad Pharma plans to take stake in Belgian company to introduce mRNA vaccine technology
Time of Update: 2020-06-06
According to the announcement, eTheRNA is a clinical-stage mRNA (ribonucleic acid) new vaccine technology company founded in 2013 by Professor Kris Thielemans, a renowned immunologist from the Free University of Brussels, and other partners, and has
7 A-share listed pharmaceutical companies with a market value of more than 100 billion yuan, "pharma one brother" status or change?
Time of Update: 2020-05-29
Pharmaceutical Network Market Analysis ) Recently, the news that Stone Pharmaceutical Group will go to Science and Technology Board has aroused high concern and discussion in the industry. At the same time, Stone Pharmaceuticals also
'Pharma Headline' Blonde Technology Wins $6.9 Billion Mask Order from U.S. Company
Time of Update: 2020-05-19
(2020/05/19) 69% more efficient than Truvada! ViiV early termination of an HIV prevention phase 3 trial; Moderna's new crown vaccine breakthrough vaccine to save the world's script to save the world staged around the world; the retail price
Shanghai Pharma plans to buy pharmaceutical technology company for 588 million yuan
Time of Update: 2020-05-12
June 16, according to Hong Kong media, Shanghai Pharmaceutical announced that it intends to pay 537.9 million yuan in cash (RMB, the same below), to Buy 50% of Xinhai Fengyuan from Inner Mongolia Yili Energy, Shaanxi Huaxin 70
Zealand Pharma, a biopharmaceutical company, acquired cycle to develop peptide targeted drugs for inflammatory bowel disease
Time of Update: 2019-10-24
In cooperation with several pharmaceutical companies, cycle has developed a macrocyclic peptide screening platform, laying a foundation for peptide drug research and development.
Fosun Pharmaceutical acquired Indian pharmaceutical company Gl Pharma with 7.2 billion yuan
Time of Update: 2017-10-09
Source: 7.2 billion pharmaceutical companies' sky high price acquisition of cypress blue 2017-10-09 finally fell
▍ during the long National Day holiday, Fosun
Step Pharma will set up an insurance company with its subsidiaries
Time of Update: 2017-03-02
(hereinafter referred to as "Bai'an online property insurance"), and Xianyang changtao electronic intends to hold 6.34% of the shares of Bai'an online property insurance, existing with Jilin Life Insurance Co., Ltd. established this time Potential industry competition.
Tiger Pharma acquired 70% of the shares of South Korean companies and seized the cro resources in Asia Pacific Region
Time of Update: 2015-06-15
On June 6, Hong Kong Tiger Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of the company, signed the share acquisition agreement with the counterparty leenos Corp.
Fierce Pharma: the top 7 pharmaceutical companies with the largest number of layoffs in 2014
Time of Update: 2015-04-08
In fact, the total number of layoffs of the seven pharmaceutical giants in this year was only 10691.
Roche's US $450 million acquisition of santaris Pharma, a Danish pharmaceutical company
Time of Update: 2014-08-06
According to the agreement signed by both parties, Roche will pay 250 million US dollars in advance and 200 million US dollars in the balance after the products reach the expected target.